Cargando…

Similarities and Differences Between Therapy-Related and Elderly Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clonal disorder of the hematopoietic stem cell, typical of the elderly, with a median age of over 60 years at diagnosis. In AML, older age is one of the strongest independent adverse prognostic factor, associated with decreased complete response rate, worse disease-...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Alò, Francesco, Fianchi, Luana, Fabiani, Emiliano, Criscuolo, Marianna, Greco, Mariangela, Guidi, Francesco, Pagano, Livio, Leone, Giuseppe, Voso, Maria Teresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2011
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248329/ https://www.ncbi.nlm.nih.gov/pubmed/22220249 http://dx.doi.org/10.4084/MJHID.2011.052

Ejemplares similares

Therapy-related myeloid neoplasms: clinical perspectives
por: Fianchi, Luana, et al.
Publicado: (2018)

New Treatments for Myelodysplastic Syndromes
por: D’Alò, Francesco, et al.
Publicado: (2010)

Incidence of Acute Myeloid Leukemia after Breast Cancer
por: Valentini, Caterina Giovanna, et al.
Publicado: (2011)

Outcome of therapy-related myeloid neoplasms treated with azacitidine
por: Fianchi, Luana, et al.
Publicado: (2012)

Epigenetic Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemias
por: Leone, Giuseppe, et al.
Publicado: (2008)

5-Azacytidine in Chronic Myelomonocytic Leukemia: Case Report and Review of Literature.
por: Greco, M., et al.
Publicado: (2011)

Risk of infection in elderly patients with AML and MDS treated with hypomethylating agents
por: Livio, Pagano, et al.
Publicado: (2018)

Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years’ Experience
por: Fianchi, Luana, et al.
Publicado: (2021)

Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia
por: Scardocci, A, et al.
Publicado: (2006)

Mastocytosis: One Word for Different Diseases
por: Criscuolo, Marianna, et al.
Publicado: (2018)

Disseminated Geosmithia argillacea Infection in a Patient with Ph-Positive Acute Lymphoblastic Leukemia. Case Report and Literature Review
por: Giordano, Antonio, et al.
Publicado: (2021)

Clonal evolution in therapy-related neoplasms
por: Fabiani, Emiliano, et al.
Publicado: (2017)

The Role of Forkhead Box Proteins in Acute Myeloid Leukemia
por: Gurnari, Carmelo, et al.
Publicado: (2019)

Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes
por: Falconi, Giulia, et al.
Publicado: (2018)

Infectious complications during monoclonal antibodies treatments and cell therapies in Acute Lymphoblastic Leukemia
por: Quattrone, Martina, et al.
Publicado: (2023)

Therapy-Related Myeloid Neoplasms: Predisposition and Clonal Evolution
por: Fabiani, Emiliano, et al.
Publicado: (2023)

The Venetoclax/Azacitidine Combination Targets the Disease Clone in Acute Myeloid Leukemia, Being Effective and Safe in a Patient with COVID-19
por: Cristiano, Antonio, et al.
Publicado: (2022)

Fanconi anemia gene variants in therapy-related myeloid neoplasms
por: Voso, M T, et al.
Publicado: (2015)

Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis
por: Guarnera, Luca, et al.
Publicado: (2022)

De Novo and Therapy-Related Myelodysplastic Syndromes: Analogies and Differences
por: Leone, Giuseppe, et al.
Publicado: (2022)

Mutational profile of ZBTB16‐RARA‐positive acute myeloid leukemia
por: Fabiani, Emiliano, et al.
Publicado: (2021)

Severe CMV Infection after Chemo-Immunotherapy with Dose-Reduced Bendamustine and Rituximab in a Mantle Cell Lymphoma Old Patient
por: Magliano, Gabriele, et al.
Publicado: (2021)

P478: MOLECULAR CHARACTERIZATION OF EXTRAMEDULLARY LOCALIZATIONS IN ACUTE MYELOID LEUKEMIA (AML)
por: Silvestrini, Giorgia, et al.
Publicado: (2023)

Targeting Chromatin Regulation in Acute Myeloid Leukemia
por: Richardson, Simon E., et al.
Publicado: (2021)

Clinical Aspects and Therapy of Sporadic Burkitt Lymphoma
por: Pagano, Livio, et al.
Publicado: (2009)

Treatment of Low-Blast Count AML using Hypomethylating Agents
por: De Bellis, Eleonora, et al.
Publicado: (2017)

Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life Experience
por: Molica, Matteo, et al.
Publicado: (2022)

Vitamin C Deficiency in Patients With Acute Myeloid Leukemia
por: Ottone, Tiziana, et al.
Publicado: (2022)

From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression
por: Gurnari, Carmelo, et al.
Publicado: (2021)

Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting
por: Attardi, Enrico, et al.
Publicado: (2023)

Case of metastatic melanoma in bone marrow smear
por: Frioni, Filippo, et al.
Publicado: (2022)

Why does the Aβ peptide of Alzheimer share structural similarity with antimicrobial peptides?
por: Pastore, Annalisa, et al.
Publicado: (2020)

How I Manage Patients with Chronic Myeloid Leukemia (CML): Perspectives from Clinical Practice
por: Guru Murthy, Guru Subramanian
Publicado: (2022)

Advances in culture methods for acute myeloid leukemia research
por: Syama, Krishnapriya, et al.
Publicado: (2021)

P499: APPLICABILITY OF 2022 CLASSIFICATIONS OF ACUTE MYELOID LEUKEMIA IN THE REAL-WORLD SETTING
por: Attardi, Enrico, et al.
Publicado: (2023)

Epidemiology of Therapy-Related Myeloid Neoplasms After Treatment for Pediatric Acute Lymphoblastic Leukemia in the Nordic Countries.
por: Schmiegelow, Kjeld
Publicado: (2011)

Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia: Emerging Options and Pending Questions
por: Wouters, Bas J.
Publicado: (2021)

Characterization of FLT3-ITD(mut) acute myeloid leukemia: molecular profiling of leukemic precursor cells
por: Travaglini, Serena, et al.
Publicado: (2020)

CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma
por: Cuccaro, Annarosa, et al.
Publicado: (2016)

From Bench to Bedside and Beyond: Therapeutic Scenario in Acute Myeloid Leukemia
por: Gurnari, Carmelo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6cpfer8ce4hge8c5o7jo5al4g7